Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 23, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-08
DOI
10.1007/s11912-020-01002-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
- (2020) Lili Zhang et al. EUROPEAN HEART JOURNAL
- Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis
- (2020) Magid Awadalla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tocilizumab for refractory severe immune checkpoint inhibitor–associated myocarditis
- (2020) J. Doms et al. ANNALS OF ONCOLOGY
- COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection
- (2020) Hasan K. Siddiqi et al. Journal of Cardiovascular Translational Research
- Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
- (2020) Carlo G Tocchetti et al. CARDIOVASCULAR RESEARCH
- Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis
- (2020) Lili Zhang et al. CIRCULATION
- Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma
- (2020) Angélique Brunot et al. JAMA Dermatology
- Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
- (2019) Magid Awadalla et al. Journal for ImmunoTherapy of Cancer
- Cardiovascular toxicities associated with immune checkpoint inhibitors
- (2019) Jiun-Ruey Hu et al. CARDIOVASCULAR RESEARCH
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms
- (2019) Samantha N. Champion et al. MODERN PATHOLOGY
- Vasculitis associated with immune checkpoint inhibitors—a systematic review
- (2018) Anisha Daxini et al. CLINICAL RHEUMATOLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune-mediated Pericarditis With Pericardial Tamponade During Nivolumab Therapy
- (2018) Daniel V.P. de Almeida et al. JOURNAL OF IMMUNOTHERAPY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Checkpoint Inhibitor‐Associated Myocarditis
- (2018) Sarju Ganatra et al. ONCOLOGIST
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Immune Checkpoint Inhibitor Toxicity in 2018
- (2018) Douglas B. Johnson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
- (2018) Vanessa M. Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors
- (2018) Gilda Varricchi et al. LANCET ONCOLOGY
- Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease
- (2017) Alida L.P. Caforio et al. EUROPEAN HEART JOURNAL
- Smoldering myocarditis following immune checkpoint blockade
- (2017) Timothy G. Norwood et al. Journal for ImmunoTherapy of Cancer
- Plasma brain natriuretic peptide levels are elevated in patients with cancer
- (2017) Sachiko Bando et al. PLoS One
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion
- (2016) Igal Kushnir et al. CARDIOLOGY
- Pericardial effusion with tamponade physiology induced by nivolumab
- (2016) Jennifer Nesfeder et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
- (2016) Lucie Heinzerling et al. Journal for ImmunoTherapy of Cancer
- Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity
- (2015) Michael Hughes et al. ANNALS OF THE RHEUMATIC DISEASES
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- 2015 ESC Guidelines for the diagnosis and management of pericardial diseases
- (2015) Yehuda Adler et al. EUROPEAN HEART JOURNAL
- Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
- (2015) Noemi Pavo et al. HEART
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myocardial oedema in acute myocarditis detected by echocardiographic 2D myocardial deformation analysis
- (2015) B.B. Løgstrup et al. European Heart Journal-Cardiovascular Imaging
- VISTA Is an Immune Checkpoint Molecule for Human T Cells
- (2014) J. L. Lines et al. CANCER RESEARCH
- Paraneoplastic polyarteritis nodosa with cerebral masses: case report and literature review
- (2014) David Veitch et al. International Journal of Rheumatic Diseases
- The immune checkpoint inhibitors: where are we now?
- (2014) Rachel M. Webster NATURE REVIEWS DRUG DISCOVERY
- The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors
- (2013) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Tim-3 Expression Defines Regulatory T Cells in Human Tumors
- (2013) Jing Yan et al. PLoS One
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
- (2012) J. C. Jennette et al. ARTHRITIS AND RHEUMATISM
- Update on Myocarditis
- (2012) Ingrid Kindermann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cancer immunotherapy – revisited
- (2011) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis
- (2009) L. Kamesh et al. RHEUMATOLOGY
- Polymorphisms in PDCD1 gene are not associated with Wegener’s granulomatosis
- (2009) Priya Sakthivel et al. RHEUMATOLOGY INTERNATIONAL
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now